Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Clinical trial NCT04981119 · RECRUITING
Trial details
- NCT number
- NCT04981119
- Sponsor
- A2 Biotherapeutics Inc.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-29
- Primary completion
- 2028-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.